Influence of tumor-associated E-cadherin mutations on tumorigenicity and metastasis

Area of Science:

• Oncology
• Molecular Biology
• Cell Adhesion

Background:

• E-cadherin is a crucial cell adhesion molecule with known tumor-suppressive functions.
• Mutations in E-cadherin are frequently observed in various cancers, but their specific impact on tumor suppression and metastasis is not fully understood.

Purpose of the Study:

• To investigate how specific tumor-associated E-cadherin mutations (exon 8 deletion, exon 9 deletion, exon 8 point mutation) affect its tumor-suppressive activity.
• To determine the influence of these E-cadherin mutations on metastasis formation in a preclinical mouse model.

Main Methods:

• Stable transfection of human breast carcinoma cells (MDA-MB-435S) with wild-type (wt) or mutant E-cadherin.
• Injection of transfected cells into the mammary fat pad of immunodeficient mice.
• Tumor growth monitoring and analysis of lung metastasis formation.
• Immunohistochemical analysis of E-cadherin expression in tumors and metastases.

Main Results:

• Wild-type E-cadherin expression significantly reduced tumor size compared to parental cells.
• Exon 9 deletion and exon 8 point mutations impaired E-cadherin's tumor-suppressive function, resulting in medium-sized tumors.
• Exon 8 deletion did not significantly affect tumor size compared to wild-type E-cadherin.
• All cell lines induced lung metastases, with no significant differences observed between groups.
• Tumors showed heterogeneous E-cadherin expression, while metastases were consistently E-cadherin negative.

Conclusions:

• The impact of E-cadherin mutations on tumor suppression is mutation-specific.
• While certain E-cadherin mutations can compromise tumor suppression, they did not significantly alter metastasis formation in this model.
• Loss or down-regulation of E-cadherin is a common feature in both primary tumors and metastases, highlighting its critical role in cell adhesion and tumor progression.